CClinicalTrials.gg
CompletedNCT00535444Updated Apr 14, 2026

Health and Faith Working to Control Blood Pressure

An interventional study of Parish nurse visit in Hypertension, sponsored by University of California, Los Angeles. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Faith community nursing programs have grown out of churches as a response to the inequity of healthcare delivery to uninsured and underinsured communities. These programs provide outreach to community members and extend their services beyond just the parishioners of the churches, reaching more uninsured people than traditional medical services. Although faith community nursing programs have been established throughout the United States, no evaluation of these programs has been done. QueensCare is taking the lead in measuring the effect of parish nurses on health outcomes. In this project we have one specific aim: to measure the effect of parish nurse visits on blood pressure control on community-dwelling hypertensive patients. Our study will involve recruiting hypertensive patients from parish nurse led health fairs and interviewing subjects at the time of recruitment. Patients will either be randomized to parish nurse visits or primary care physician appointments. We will have a 4-month follow-up period with a re-check of blood pressures and an exit interview of the patient. From this study, we hope to better understand if parish nurse visits improve blood pressure and medication compliance among hypertensive patients.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Hypertension
  • parish nurse
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 100 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,142 studies on the registry; 192 are open to participants now.

Of its 91 completed or terminated interventional studies of FDA-regulated products, 66 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • We will be including adults who are 18 years and older who have attended a health fair or screening event at one of QueensCare Health and Faith Partnership parish nurse sponsored church events in Los Angeles.
  • Patients must be either English or Spanish speaking.
  • Patients will be enrolled by blood pressure readings at the screening event. We will be using the JNC 71 criteria for diagnosing hypertension.
  • Patients with blood pressures above 140/90 will be defined as hypertensive.
  • Diagnosed and previously undiagnosed hypertensive patients will be included in the study.
  • The patient must also be able to come to the follow-up appointment in 4 months.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women will not be included in the study.
  • Patients who do not speak English or Spanish will be excluded from the study since we do not have the capacity to translate all our materials into multiple languages.
  • Those deemed by the research assistant to be incapable to give informed consent (due to intoxication, dementia, or other causes) will also be excluded from the study.
  • Patients younger than 18 years old will be excluded from the study.
  • Patients who have seen a parish nurse in her office hours in the past 6 months will be excluded from the study. We do not want patients who have an already established relationship with a parish nurse to be enrolled in the study with the chance of being randomized to the physician-only arm, which would interrupt the continuity of care the patient is receiving from the parish nurse.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    Control

    assisted appointment with physician

    Other: Parish nurse visit

Interventions

  • OtherParish nurse visit

    One visit with the parish nurse in 2 weeks

06

What researchers measure

Primary outcomes

  1. Drop of 12.5 mm Hg in systolic blood pressure

    Time frame: within 4 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00535444
Lead sponsor
University of California, Los Angeles
Collaborators
Robert Wood Johnson Foundation
Responsible party
Sponsor
First posted
Sep 26, 2007
Start date
Sep 2006
Primary completion
Oct 2007
Completion
Oct 2007
Last update
Apr 14, 2026

Study contacts

Arshiya A Baig, MD/MPH
principal investigator · UCLA RWJ CSP

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion